| In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2 BG Vijayakumar, D Ramesh, A Joji, T Kannan European journal of pharmacology 886, 173448, 2020 | 139 | 2020 |
| Indole chalcones: Design, synthesis, in vitro and in silico evaluation against Mycobacterium tuberculosis D Ramesh, A Joji, BG Vijayakumar, A Sethumadhavan, M Mani, T Kannan European Journal of Medicinal Chemistry 198, 112358, 2020 | 74 | 2020 |
| Jayachandra prakasan, J.; Kannan, T. In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of … BG Vijayakumar, D Ramesh, A Joji Eur. J. Pharmacol 886 (173448), 10.1016, 2020 | 21 | 2020 |
| First‐in‐class pyrido[2,3‐d]pyrimidine‐2,4(1H,3H)‐diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights D Ramesh, D Sarkar, A Joji, M Singh, AK Mohanty, B G. Vijayakumar, ... Archiv der Pharmazie 355 (4), 2100440, 2022 | 8 | 2022 |
| Carbon dots as dual inhibitors of tau and amyloid-beta aggregation for the treatment of Alzheimer's disease W Zhang, N Smith, Y Zhou, CM McGee, M Bartoli, S Fu, J Chen, ... Acta Biomaterialia, 2024 | 4 | 2024 |
| Erratum: First‐in‐class pyrido[2,3‐d]pyrimidine‐2,4(1H,3H)‐diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic … D Ramesh, D Sarkar, A Joji, M Singh, AK Mohanty, BG Vijayakumar, ... Archiv der Pharmazie 355 (4), 2270007, 2022 | | 2022 |
